• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cardiol Cases . Acute myocarditis after receiving first dose of BNT162b2 mRNA vaccine

tetano

Editor, Senior Moderator
J Cardiol Cases


. 2022 Jan 7.
doi: 10.1016/j.jccase.2021.12.009. Online ahead of print.
Acute myocarditis after receiving first dose of BNT162b2 mRNA vaccine


Bryan Wu[SUP] 1 [/SUP], Nikita Mittal[SUP] 1 [/SUP], Eric D Adler[SUP] 1 [/SUP], Kimberly N Hong[SUP] 1 [/SUP]



Affiliations

Abstract

A 40-year-old man with history of prior coronavirus disease 2019 (COVID-19) infection developed pleuritic chest pain 3 days after receiving the first dose of the BNT162b2 mRNA vaccine. Echocardiography results were significant for mild dysfunction and left ventricular hypertrophy. Cardiac magnetic resonance imaging showed myocardial edema as well as delayed enhancement in the inferior wall of the basal left ventricular myocardium, suggestive of acute myocarditis. This case describes the work-up, diagnosis, risk-stratification, and management of acute myocarditis post BNT162b2 mRNA vaccine.

Keywords: BNT162b2 mRNA vaccine; Coronavirus 2019; Myocarditis; Pneumonia.
 
Back
Top Bottom